Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Clinical hold extended for ORTHO-R phase I/II study

Aug. 23, 2021

Shenzhen Salubris Pharmaceuticals presents new cathepsin K inhibitors

Aug. 13, 2021

Topline phase II data with Sarconeos in sarcopenia

Aug. 2, 2021

New glucocorticoid receptor modulators identified at Medshine Discovery

Aug. 2, 2021

Nuclear receptor ROR-gamma modulators discovered at Nuevolution

July 16, 2021

Enrollment opens in first-in-human study of VIB-1116 for rheumatic diseases

July 15, 2021

Carna reports phase I SAD data on BTK inhibitor AS-0871

July 13, 2021

Landos Biopharma patents new LANCL2 activators

July 9, 2021

SHR-1314 studied in phase II/III trial for active ankylosing spondylitis

July 5, 2021

LG Chem reports data from phase II CLUE study of LC-350189 in chronic gout

July 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...